UBS ASSET MANAGEMENT AMERICAS LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q3 2014$1,260,000
-43.9%
9,600
-46.1%
0.00%
-50.0%
Q2 2014$2,245,000
-49.3%
17,800
-47.0%
0.00%
-60.0%
Q1 2014$4,429,000
+7.5%
33,600
-4.3%
0.01%0.0%
Q4 2013$4,120,000
+13.2%
35,100
+0.6%
0.01%
+25.0%
Q3 2013$3,641,000
+213.3%
34,900
+158.5%
0.00%
+300.0%
Q2 2013$1,162,00013,5000.00%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2013
NameSharesValueWeighting ↓
Brave Warrior Advisors 5,701,010$1,266,479,00036.57%
Ruane, Cunniff & Goldfarb 33,884,050$7,527,342,00035.90%
LeVasseur Capital Partners LLC 188,804$41,943,00034.97%
Pershing Square Capital Management 19,473,933$4,326,134,00029.95%
FARLEY CAPITAL L.P. 141,020$31,328,00024.16%
Ratan Capital Management LP 1,038,033$230,599,00021.97%
Marble Arch Investments 1,069,000$237,478,00020.47%
Arrow Capital Management, LLC 144,461$32,092,00018.04%
Tesuji Partners 1,368,040$303,910,00017.93%
ValueAct Holdings 14,994,261$3,330,975,00017.54%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders